Endocrinology, Vol 134, 2468-2474, Copyright © 1994 by Endocrine Society

ARTICLES

Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells

IM Bird, JI Mason and WE Rainey
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.

We have studied the hormonal regulation of type 1 angiotensin-II receptor (AT1-R) mRNA expression and [125I]angiotensin-II ([125I]AII) binding in human adrenocortical carcinoma H295 cells, which exhibit predominantly AT1-subtype receptors. Activation of the cAMP signaling pathway with forskolin or (Bu)2cAMP caused a rapid decrease in AT1-R mRNA levels (decreased 65% within 3 h). This preceded a time-dependent (maximal, 70% within 12 h) and dose-dependent (IC50, 2 microM forskolin) loss of [125I]AII binding together with decreased phosphoinositidase-C activation (72% decrease) on subsequent AII challenge. Thus, the decreases in AT1-R mRNA levels and functional receptor expression parallel each other in response to activation of protein kinase-A. AII treatment also caused a rapid loss in AT1-R mRNA (maximal, 80% decrease within 3 h), but 48-h treatment caused both [125I]AII binding and the subsequent phosphoinositidase-C response to decrease by only 6% (P < 0.05) and 22% (P < 0.05), respectively. The effect of AII on AT1-R mRNA levels was fully reproduced by the combination of calcium ionophore (A23187) and phorbol ester (12-O- tetradecanoylphorbol 13-acetate), suggesting that AII action was through protein kinase-C and possibly other Ca(2+)-sensitive protein kinases. The effect of AII, but not forskolin, was reversed by treatment in the presence of cycloheximide. In conclusion, control of AT1-R expression is differentially regulated by adenylate cyclase and phosphoinositidase-C signaling pathways, which act at multiple levels in human adrenocortical cells.

This article has been cited by other articles:

				H. Otani, F. Otsuka, K. Inagaki, J. Suzuki, T. Miyoshi, Y. Kano, J. Goto, T. Ogura, and H. Makino Aldosterone Breakthrough Caused by Chronic Blockage of Angiotensin II Type 1 Receptors in Human Adrenocortical Cells: Possible Involvement of Bone Morphogenetic Protein-6 Actions Endocrinology, June 1, 2008; 149(6): 2816 - 2825. [Abstract] [Full Text] [PDF]

				J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function Endocr. Rev., April 1, 2008; 29(2): 133 - 154. [Abstract] [Full Text] [PDF]

				E. F Nogueira, C. A Vargas, M. Otis, N. Gallo-Payet, W. B Bollag, and W. E Rainey Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells J. Mol. Endocrinol., December 1, 2007; 39(6): 365 - 374. [Abstract] [Full Text] [PDF]

				E. Samandari, P. Kempna, J.-M. Nuoffer, G. Hofer, P. E Mullis, and C. E Fluck Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3{beta}-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities J. Endocrinol., December 1, 2007; 195(3): 459 - 472. [Abstract] [Full Text] [PDF]

				Kai Chen, D. C. Merrill, and J. C. Rose The Importance of Angiotensin II Subtype Receptors for Blood Pressure Control During Mouse Pregnancy Reproductive Sciences, October 1, 2007; 14(7): 694 - 704. [Abstract] [PDF]

				D. G Romero, M. Y. Zhou, L. L Yanes, M. W Plonczynski, T. R Washington, C. E Gomez-Sanchez, and E. P Gomez-Sanchez Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion J. Endocrinol., August 1, 2007; 194(2): 429 - 440. [Abstract] [Full Text] [PDF]

				K. Inagaki, F. Otsuka, J. Suzuki, Y. Kano, M. Takeda, T. Miyoshi, H. Otani, Y. Mimura, T. Ogura, and H. Makino Involvement of Bone Morphogenetic Protein-6 in Differential Regulation of Aldosterone Production by Angiotensin II and Potassium in Human Adrenocortical Cells Endocrinology, June 1, 2006; 147(6): 2681 - 2689. [Abstract] [Full Text] [PDF]

				J. M C Connell and E. Davies The new biology of aldosterone J. Endocrinol., July 1, 2005; 186(1): 1 - 20. [Abstract] [Full Text] [PDF]

				J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells Endocrinology, February 1, 2004; 145(2): 639 - 649. [Abstract] [Full Text] [PDF]

				C. Zeng, Y. Luo, L. D. Asico, U. Hopfer, G. M. Eisner, R. A. Felder, and P. A. Jose Perturbation of D1 Dopamine and AT1 Receptor Interaction in Spontaneously Hypertensive Rats Hypertension, October 1, 2003; 42(4): 787 - 792. [Abstract] [Full Text] [PDF]

				J. Gu, Y. Wen, A. Mison, and J. L. Nadler 12-Lipoxygenase Pathway Increases Aldosterone Production, 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein Phosphorylation, and p38 Mitogen-Activated Protein Kinase Activation in H295R Human Adrenocortical Cells Endocrinology, February 1, 2003; 144(2): 534 - 543. [Abstract] [Full Text] [PDF]

				M. M. Martin, B. M. Willardson, G. F. Burton, C. R. White, J. N. McLaughlin, S. M. Bray, J. W. Ogilvie Jr., and T. S. Elton Human Angiotensin II Type 1 Receptor Isoforms Encoded by Messenger RNA Splice Variants Are Functionally Distinct Mol. Endocrinol., February 1, 2001; 15(2): 281 - 293. [Abstract] [Full Text]

				C. L. Coulter, D. A. Myers, P. W. Nathanielsz, and I. M. Bird Ontogeny of Angiotensin II Type 1 Receptor and Cytochrome P450c11 in the Sheep Adrenal Gland Biol Reprod, March 1, 2000; 62(3): 714 - 719. [Abstract] [Full Text]

				D. Rozman, M. Fink, G. M. Fimia, P. Sassone-Corsi, and M. R. Waterman Cyclic Adenosine 3',5'-Monophosphate(cAMP)/cAMP-Responsive Element Modulator (CREM)-Dependent Regulation of Cholesterogenic Lanosterol 14{alpha}-Demethylase (CYP51) in Spermatids Mol. Endocrinol., November 1, 1999; 13(11): 1951 - 1962. [Abstract] [Full Text]

				G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF]

				J.-G. Lehoux, A. Fleury, and L. Ducharme The Acute and Chronic Effects of Adrenocorticotropin on the Levels of Messenger Ribonucleic Acid and Protein of Steroidogenic Enzymes in Rat Adrenal in Vivo Endocrinology, September 1, 1998; 139(9): 3913 - 3922. [Abstract] [Full Text] [PDF]

				I. M. Bird, D. S. Millican, and R. R. Magness Specific Pregnancy-Induced Angiotensin II Type-1 Receptor Expression in Ovine Uterine Artery Does Not Involve Formation of Alternate Splice Variants or Alternate Promoter Usage Biol Reprod, August 1, 1998; 59(2): 219 - 224. [Abstract] [Full Text]

				G. P. Rossi, G. Albertin, S. Bova, A. S. Belloni, F. Fallo, U. Pagotto, L. Trevisi, G. Palu, A. C. Pessina, and G. G. Nussdorfer Autocrine-Paracrine Role of Endothelin-1 in the Regulation of Aldosterone Synthase Expression and Intracellular Ca2+ in Human Adrenocortical Carcinoma NCI-H295 Cells Endocrinology, October 1, 1997; 138(10): 4421 - 4426. [Abstract] [Full Text] [PDF]

				R. Ouali, M.-C. Berthelon, M. Begeot, and J. M. Saez Angiotensin II Receptor Subtypes AT1 and AT2 Are Down-Regulated by Angiotensin II through AT1 Receptor by Different Mechanisms Endocrinology, February 1, 1997; 138(2): 725 - 733. [Abstract] [Full Text] [PDF]

				I. M. Bird, J. Zheng, J. M. Cale, and R. R. Magness Pregnancy Induces an Increase in Angiotensin II Type-1 Receptor Expression in Uterine But Not Systemic Artery Endothelium Endocrinology, January 1, 1997; 138(1): 490 - 498. [Abstract] [Full Text] [PDF]

				D.-F. Guo, S. Uno, A. Ishihata, N. Nakamura, and T. Inagami Identification of a cis-Acting Glucocorticoid Responsive Element in the Rat Angiotensin II Type 1A Promoter Circ. Res., August 1, 1995; 77(2): 249 - 257. [Abstract] [Full Text]

				I. M. Bird, R. A. Word, C. Clyne, J. I. Mason, and W. E. Rainey Potassium Negatively Regulates Angiotensin II Type 1 Receptor Expression in Human Adrenocortical H295R Cells Hypertension, June 1, 1995; 25(6): 1129 - 1134. [Abstract] [Full Text]